Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry
Top Cited Papers
Open Access
- 15 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (10) , 1208-1218
Abstract
Rationale: Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. Objectives: We hypothesized that structural change would be detected early in the natural history of COPD and would relate to loss of lung function with time. Methods: We recruited 431 current smokers (median age, 39 yr; 16 pack-years smoked) and recorded symptoms using the COPD Assessment Test (CAT), spirometry, and quantitative thoracic computed tomography (QCT) scans at study entry. These scan results were compared with those from 67 never-smoking control subjects. Three hundred sixty-eight participants were followed every six months with measurement of postbronchodilator spirometry for a median of 32 months. The rate of FEV1 decline, adjusted for current smoking status, age, and sex, was related to the initial QCT appearances and symptoms, measured using the CAT. Measurements and Main Results: There were no material differences in demography or subjective CT appearances between the young smokers and control subjects, but 55.7% of the former had CAT scores greater than 10, and 24.2% reported chronic bronchitis. QCT assessments of disease probability–defined functional small airway disease, ground-glass opacification, bronchovascular prominence, and ratio of small blood vessel volume to total pulmonary vessel volume were increased compared with control subjects and were all associated with a faster FEV1 decline, as was a higher CAT score. Conclusions: Radiological abnormalities on CT are already established in young smokers with normal lung function and are associated with FEV1 loss independently of the impact of symptoms. Structural abnormalities are present early in the natural history of COPD and are markers of disease progression. Clinical trial registered with www.clinicaltrials.gov (NCT 03480347).Keywords
Funding Information
- NIH (HL-11298)
- NIH (HL-11298)
This publication has 37 references indexed in Scilit:
- Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation studyThe Lancet Digital Health, 2023
- Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung FunctionChest, 2021
- CT image segmentation for inflamed and fibrotic lungs using a multi-resolution convolutional neural networkScientific Reports, 2021
- Update on the Pathogenesis of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2019
- Update on Clinical Aspects of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2019
- A Novel Method of Estimating Small Airway Disease Using Inspiratory-to-Expiratory Computed TomographyRespiration, 2017
- Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2015
- Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionNature Medicine, 2012
- Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokersProceedings of the National Academy of Sciences, 2010
- The natural history of chronic airflow obstruction.BMJ, 1977